Applied Clinical Trials
July 01, 2019
Issue PDF
28
7
Click the title above to open the Applied Clinical Trials July/August 2019 issue in an interactive PDF format.
July 01, 2019
News
28
7
Yaky Yanay, CEO of Pluristem, will discuss his experience and the strategies Pluristem implemented in regenerative medicine clinical trials.
July 01, 2019
Feature Articles
28
7
Methods sponsors and CROs can use to minimize the growing pains associated with RBM implementation.
July 01, 2019
News
28
7
Patient advocates debate whether FDA approval on small, early clinical studies is too fast-tracked for efficacy and safety, or too slow due to long review processes.
July 01, 2019
Feature Articles
28
7
Addressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
July 01, 2019
From the Editor
28
7
A look at the opportunities and challenges around patient-centric trials and patient centricity in pharma.
July 01, 2019
News
28
7
The consequences UK faces after being pulled out of the EU without any healthcare and research deal may affect all of Europe.
July 01, 2019
Feature Articles
28
7
Navigating the many complexities in clinical trials, manufacturing, and regulatory interaction in moving gene therapies from development to market.
July 01, 2019
Feature Articles
28
7
Exploring the use of electronic investigator site files for review of regulatory documents and informed consents.
July 01, 2019
A Closing Thought
28
7
While obstacles may persist with limited access for patients and researchers, technology can help with this cancer clinical trial paradox.